Verastem Inc (VSTM)
Healthcare
Biotechnology
5.70 $
-1.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Verastem Inc (VSTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -138 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37 | -46 | -29 | -57 | -75 | -139 | -34 | -54 | -64 | -86 | -105 | -138 | |
| 0.4 | 0.8 | 0.7 | 0.6 | 1.4 | 2.2 | 1.3 | 0.1 | 0.0 | 0.1 | 0.0 | 0.7 | |
| 12 | 10 | 6.3 | 5.0 | 6.7 | 8.5 | 8.1 | 7.7 | 6.0 | 5.9 | 7.3 | 9.4 | |
| 12 | 9.7 | 6.2 | 5.0 | 6.6 | 8.5 | 11 | 7.7 | 6.0 | – | – | – | |
| 2.2 | 1.2 | 0.1 | 4.7 | 14 | -7.8 | 12 | 0.6 | 3.9 | -1.0 | 3.7 | 26 | |
| 2.4 | 0.2 | 0.0 | 1.5 | 24 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 9.6 | |
| 43 | -27 | 37 | 44 | -138 | 90 | -47 | 0.1 | 66 | -44 | 60 | -9.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 9.6 | 64 | 0.0 | 49 | 106 | -0.1 | -0.3 | -0.9 | 28 | – | – | – | |
| 15 | 15 | 15 | 15 | 155 | -2.5 | -37 | 1.1 | 24 | 15 | -0.2 | 32 | |
| 8.8 | 64 | 0.0 | 63 | 261 | -2.4 | 70 | 6.9 | 52 | 134 | 55 | 263 | |
| 15 | -9.0 | 7.5 | 50 | 48 | -51 | -11 | -47 | 54 | 3.3 | 10.0 | 116 | |
| -39 | -46 | -30 | -57 | -98 | -139 | -34 | -54 | -64 | -86 | -105 | -138 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.